Hi-Tech Pharmacal Co. (HITK) Misses Q1 EPS by 24c; Sales Light
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
Research and product development costs: 4.45M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Research and product development costs: 4.45M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q1 EPS of $0.44, $0.24 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $52 million versus the consensus estimate of $57.6 million.
NOTE: Shares were halted.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
NOTE: Shares were halted.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- HSBC Upgrades Pegatron Corp. (4938:TT) to Hold
- Bernstein SocGen Group Downgrades Bridgestone Corp. (5108:JP) (BRDCY) to Market Perform
Create E-mail Alert Related Categories
Earnings, Hot Earnings, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
